George Morrow is currently a Board Director at Neurocrine Biosciences and has served as a Board Director at Align Technology since 2006, where they are also the Chairman of the Compensation and Benefits Committee. Morrow was previously the President and CEO of Glaxo Wellcome Inc. from 1992 to 2001 and held the position of Executive Vice President of Global Commercial Operations at Amgen until retirement in 2011. They have also been a Board Director for several other companies, including Safeway and Otonomy Inc. Morrow holds an MBA from Duke University's Fuqua School of Business, a BS in Chemistry from Long Island University, and an MS in Biochemistry from Bryn Mawr College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices